SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001445866-18-000142
Filing Date
2018-02-06
Accepted
2018-02-06 15:14:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A arch_sc13ga.htm SC 13G/A 38289
  Complete submission text file 0001445866-18-000142.txt   39667
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Subject) CIK: 0001537561 (see all company filings)

IRS No.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-87522 | Film No.: 18577370
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O NEXT PHASE ENTERPRISES 4020 NORTH 20TH STREET, SUITE 305 PHOENIX AZ 85016
Business Address
Parker Michael Andrew (Filed by) CIK: 0001653850 (see all company filings)

Type: SC 13G/A